Methods of diagnosing and treating neuropsychiatric diseases and disorders
OwnerChristopher Pittenger, Jian Xu +1inventors
InventorsChristopher Pittenger, Jian Xu, Aaron Ring
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of diagnosing neuropsychiatric diseases and disorders by means of identifying antigens that bind to specific cells in whole neural tissue. In a non-limiting example, a method of diagnosing pediatric acute-onset neuropsychiatric syndrome (PANS) is provided.
Claims18
A method for diagnosing a neuropsychiatric disease or disorder in a human subject, the method comprising:
- i) obtaining a serum sample comprising IgG from the human subject;
- ii) quantifying using ELISA an amount of an autoantibody binding to the target antigen set in the serum sample, so as to provide an ELISA value, wherein the autoantibody comprises at least one of an anti-LRP11 antibody, an anti-CXCL3 antibody, an anti-PDGFB antibody, and an anti-CSPG5 antibody;
- and
- iii) diagnosing the human subject with PANS if the ELISA value is greater than or equal to 3 standard deviations above a control mean ELISA value.
The method of claim 12, wherein the treating comprises administering to the human subject a therapeutically effective amount of at least one of IVIG, rituximab, a steroid, and a non-steroidal anti-inflammatory drug (NSAID).
A method for identifying a disease-inducing agent in a neuropsychiatric disease or disorder, the method comprising:
- i) providing an isolated tissue sample containing cholinergic interneurons (CINs);
- ii) identifying one or more antibodies in a serum specimen that bind to the CINs:
- iii) quantifying using ELISA an amount of the one or more antibodies that bind to the CINs so as to provide an ELISA value;
- and
- iv) comparing the ELISA value against a control ELISA value to determine whether the one or more antibodies are disease-inducing agents.
Dependencies are inferred from the claim text.